| Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ... Nature genetics 46 (9), 989-993, 2014 | 2015 | 2014 |
| Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases M Steger, F Tonelli, G Ito, P Davies, M Trost, M Vetter, S Wachter, ... elife 5, e12813, 2016 | 891 | 2016 |
| Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, ... The Lancet Neurology 10 (10), 898-908, 2011 | 344 | 2011 |
| Effect of selective LRRK2 kinase inhibition on nonhuman primate lung RN Fuji, M Flagella, M Baca, MA S. Baptista, J Brodbeck, BK Chan, ... Science translational medicine 7 (273), 273ra15-273ra15, 2015 | 296 | 2015 |
| Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease KD Dave, S De Silva, NP Sheth, S Ramboz, MJ Beck, C Quang, ... Neurobiology of disease 70, 190-203, 2014 | 238 | 2014 |
| Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs MAS Baptista, KD Dave, MA Frasier, TB Sherer, M Greeley, MJ Beck, ... PloS one 8 (11), e80705, 2013 | 190 | 2013 |
| Crossroads in GDNF therapy for Parkinson's disease TB Sherer, BK Fiske, CN Svendsen, AE Lang, JW Langston Movement disorders 21 (2), 136-141, 2006 | 185 | 2006 |
| Cell death in the developing and sensory‐deprived rat olfactory bulb BK Fiske, PC Brunjes Journal of Comparative Neurology 431 (3), 311-319, 2001 | 111 | 2001 |
| Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study A Elbaz, LM Nelson, H Payami, JPA Ioannidis, BK Fiske, G Annesi, ... The Lancet Neurology 5 (11), 917-923, 2006 | 104 | 2006 |
| GDNF and Parkinson’s disease: where next? A summary from a recent workshop RA Barker, A Björklund, DM Gash, A Whone, A Van Laar, JH Kordower, ... Journal of Parkinson's disease 10 (3), 875-891, 2020 | 103 | 2020 |
| LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits MAS Baptista, K Merchant, T Barrett, S Bhargava, DK Bryce, JM Ellis, ... Science translational medicine 12 (540), eaav0820, 2020 | 101 | 2020 |
| Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ... JAMA neurology 78 (3), 312-320, 2021 | 100 | 2021 |
| The Parkinson's disease genome‐wide association study locus browser FP Grenn, JJ Kim, MB Makarious, H Iwaki, A Illarionova, K Brolin, ... Movement Disorders 35 (11), 2056-2067, 2020 | 83 | 2020 |
| Incidence of Parkinson disease in North America AW Willis, E Roberts, JC Beck, B Fiske, W Ross, R Savica, ... npj Parkinson's Disease 8 (1), 170, 2022 | 79 | 2022 |
| Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance M San Luciano, CM Tanner, C Meng, C Marras, SM Goldman, AE Lang, ... Movement Disorders 35 (10), 1755-1764, 2020 | 74 | 2020 |
| Microglial activation in the developing rat olfactory bulb BK Fiske, PC Brunjes Neuroscience 96 (4), 807-815, 2000 | 61 | 2000 |
| International Parkinson's Disease Genomics Consortium (IPDGC) MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ... Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics …, 2014 | 52 | 2014 |
| Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease D Lai, B Alipanahi, P Fontanillas, TH Schwantes‐An, J Aasly, RN Alcalay, ... Annals of neurology 90 (1), 76-88, 2021 | 42 | 2021 |
| Genetic Epidemiology Of Parkinson’s Disease (GEO-PD) Consortium. Association of LRRK2 exonic variants with susceptibility to Parkinson’s disease: a case-control study OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, ... Lancet Neurol 10 (10), 898-908, 2011 | 41 | 2011 |
| The protective effect of LRRK2 p. R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants MG Heckman, A Elbaz, AI Soto-Ortolaza, DJ Serie, JO Aasly, G Annesi, ... Neurobiology of aging 35 (1), 266. e5-266. e14, 2014 | 38 | 2014 |
Matthias TrostNewcastle University在 newcastle.ac.uk 的电子邮件经过验证
